DCGI Approves Market Authorisation for SII's Covid Vaccine Covovax as Heterologous Booster Dose

The DCGI's approval came following recommendation by the Subject Expert Committee of the Central Drugs Standard Control Organisation

Posted from: this blog via Microsoft Power Automate.


EmoticonEmoticon